Jussi O T Sipilä1, Jori O Ruuskanen2, Päivi Rautava3, Ville Kytö4. 1. Department of Neurology, North Karelia Central Hospital, Joensuu, Finland; Neurology, University of Turku, Turku, Finland; Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland. 2. Neurology, University of Turku, Turku, Finland; Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland. Electronic address: jori.ruuskanen@tyks.fi. 3. Clinical Research Center, Turku University Hospital, Turku, Finland; Department of Public Health, University of Turku, Turku, Finland. 4. Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Heart Center, Turku University Hospital, Turku, Finland.
Abstract
BACKGROUND: Circadian rhythm disruption has been associated with increased risk of ischemic stroke (IS). Daylight saving time (DST) transitions disrupt circadian rhythms and shifts the pattern of diurnal variation in stroke onset, but effects on the incidence of IS are unknown. METHODS: Effects of 2004-2013 DST transitions on IS hospitalizations and in-hospital mortality were studied nationwide in Finland. Hospitalizations during the week following DST transition (study group, n = 3033) were compared to expected hospitalizations (control group, n = 11,801), calculated as the mean occurrence during two weeks prior to and two weeks after the index week. RESULTS: Hospitalizations for IS increased during the first two days (Relative Risk 1.08; CI 1.01-1.15, P = 0.020) after transition, but difference was diluted when observing the whole week (RR 1.03; 0.99-1.06; P = 0.069). Weekday-specific increase was observed on the second day (Monday; RR 1.09; CI 1.00-1.90; P = 0.023) and fifth day (Thursday; RR 1.11; CI 1.01-1.21; P = 0.016) after transition. Women were more susceptible than men to temporal changes during the week after DST transitions. Advanced age (>65 years) (RR 1.20; CI 1.04-1.38; P = 0.020) was associated with increased risk during the first two days, and malignancy (RR 1.25; CI 1.00-1.56; P = 0.047) during the week after DST transition. CONCLUSIONS: DST transitions appear to be associated with an increase in IS hospitalizations during the first two days after transitions but not during the entire following week. Susceptibility to effects of DST transitions on occurrence of ischemic stroke may be modulated by gender, age and malignant comorbidities.
BACKGROUND: Circadian rhythm disruption has been associated with increased risk of ischemic stroke (IS). Daylight saving time (DST) transitions disrupt circadian rhythms and shifts the pattern of diurnal variation in stroke onset, but effects on the incidence of IS are unknown. METHODS: Effects of 2004-2013 DST transitions on IS hospitalizations and in-hospital mortality were studied nationwide in Finland. Hospitalizations during the week following DST transition (study group, n = 3033) were compared to expected hospitalizations (control group, n = 11,801), calculated as the mean occurrence during two weeks prior to and two weeks after the index week. RESULTS: Hospitalizations for IS increased during the first two days (Relative Risk 1.08; CI 1.01-1.15, P = 0.020) after transition, but difference was diluted when observing the whole week (RR 1.03; 0.99-1.06; P = 0.069). Weekday-specific increase was observed on the second day (Monday; RR 1.09; CI 1.00-1.90; P = 0.023) and fifth day (Thursday; RR 1.11; CI 1.01-1.21; P = 0.016) after transition. Women were more susceptible than men to temporal changes during the week after DST transitions. Advanced age (>65 years) (RR 1.20; CI 1.04-1.38; P = 0.020) was associated with increased risk during the first two days, and malignancy (RR 1.25; CI 1.00-1.56; P = 0.047) during the week after DST transition. CONCLUSIONS: DST transitions appear to be associated with an increase in IS hospitalizations during the first two days after transitions but not during the entire following week. Susceptibility to effects of DST transitions on occurrence of ischemic stroke may be modulated by gender, age and malignant comorbidities.
Authors: Muhammad Adeel Rishi; Omer Ahmed; Jairo H Barrantes Perez; Michael Berneking; Joseph Dombrowsky; Erin E Flynn-Evans; Vicente Santiago; Shannon S Sullivan; Raghu Upender; Kin Yuen; Fariha Abbasi-Feinberg; R Nisha Aurora; Kelly A Carden; Douglas B Kirsch; David A Kristo; Raman K Malhotra; Jennifer L Martin; Eric J Olson; Kannan Ramar; Carol L Rosen; James A Rowley; Anita V Shelgikar; Indira Gurubhagavatula Journal: J Clin Sleep Med Date: 2020-10-15 Impact factor: 4.062
Authors: Michael C Antle; Mahtab Moshirpour; Patricia R Blakely; Katelyn Horsley; Colin J Charlton; Victor Hu Journal: J Biol Rhythms Date: 2022-04-05 Impact factor: 3.649